Verona Secures Up To $650M in Funding as it Gears Up for Potential COPD Approval and Launch

Anticipating approval for its COPD therapy ensifentrine, Verona has entered into a $650 million financing deal with Oaktree Capital Management and OMERS Life Sciences.